Researchers at the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knöll Institute (Leibniz-HKI) in Jena, Germany have identified an enzyme that is a promising new therapeutic target to combat ...
Aug 1, 2022
0
36
Columbia and MIT researchers are revealing the surprising reasons why cancer cells are often forced to rely on fat imports, a finding that could lead to new ways to understand and slow down tumor growth.
Jun 24, 2022
0
700
Research by Oregon State University has explained how an important type 2 diabetes drug is made in nature, opening the door to improvements in manufacturing through biotechnology.
Jun 21, 2022
0
1123
In a new article from Acta Pharmaceutica Sinica B, authors Beifen Zhong, Jun Wan and colleagues from the Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, discuss biosynthesis of rumbrins ...
Mar 8, 2022
0
2
A gene called DOT1L appears to play a role in progression and severity of ovarian cancer, and inhibitors of the DOT1L enzyme may offer a new therapeutic approach for the disease, University of Alabama at Birmingham researchers ...
Aug 5, 2021
0
292
UCLA researchers have developed a new approach that could eventually help young people respond better to treatment for acute lymphoblastic leukemia. The scientists discovered in mice that when the production of nucleotides—also ...
Aug 15, 2017
0
8
A study which includes the participation of University of Granada scientists has provided new data on the Q10 coenzyme (CoQ10), a molecule which is synthesized within the cells of the organism itself and which has essential ...
Feb 3, 2015
0
2
Researchers at the University of Granada have produced for the first time in the world mice lacking the coenzyme Q10, a rare mitochondrial disease prevailingly affecting children. The researchers needed three years to complete ...
Jan 29, 2013
0
0
